Evidence map›Paper›PMID 23937370›Full record

ArticleAmerican journal on intellectual and developmental disabilities2013

Developmental and behavioral pediatricians' attitudes toward screening for fragile X.

Kruti Acharya, Abigail Schindler

Abstract read
In one paragraph

Article in American journal on intellectual and developmental disabilities, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kruti AcharyaUniversity of Chicago, Chicago, IL 60637, USA. kacharya@peds.bsd.uchicago.edu
Abigail Schindler

Funding

The Ethics of Fragile X Genetic Screening and Testing Across the LifespanK23MH082126 · NIMH · UNIVERSITY OF CHICAGO · PI ACHARYA, KRUTI · 2008 to 2012
$721k
NIMH NIH HHS K23 MH082126
6 · The paper itself

Abstract

Developmental and behavioral pediatricians (DBP) diagnose and care for children with fragile X syndrome. Their attitudes toward FMR1 newborn screening (NBS) and FMR1 carrier testing in childhood could highlight potential pitfalls with FMR1 NBS. We conducted a cross-sectional survey with an adjusted response rate of 61%. Among DBP, 74% supported universal FMR1 NBS, preferring to identify both full mutations and premutations. DBP also support FMR1 testing of asymptomatic siblings. Although DBP support testing for premutations at various points in the lifespan, DBP are not familiar with the array of fragile X-associated disorders (FXAD). Targeted educational interventions are needed to ensure that all health care providers have the knowledge and competence to consent and to counsel families on FXAD.

Indexed as

Attitude of Health PersonnelHealth Knowledge, Attitudes, PracticeMass ScreeningAdultCross-Sectional StudiesFemaleFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeGenetic TestingHumansInfant, NewbornMaleMiddle AgedNeonatal ScreeningPhysiciansSocieties, MedicalFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1

Identifiers

PMID23937370
PMCPMC3744113

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.